Ensemble Therapeutics Corp. (extinct)

Ensemble Therapeutics Corp. (extinct)

Ensemble Therapeutics Corp. (extinct)

Overview
Date Founded

2002

Headquarters

One Broadway,14th floor,Cambridge, MA 02142

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Chemicals
Hospitals & Patient Services
Biotechnology

Company Description

Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Ensemble Therapeutics Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

Paths to Ensemble Therapeutics Corp.
Potential Connections via
Relationship Science
You
Ensemble Therapeutics Corp.
Investors
Details Hidden

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden

Co-Founder at Moderna, Inc.

Details Hidden

Managing Partner at Flagship Pioneering

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ensemble Therapeutics Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ensemble Therapeutics Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ensemble Therapeutics Corp..